Mechanism for diminished tissue factor expression by endothelial cells cultured with heparin binding growth factor-1 and heparin

We have extended our earlier observation that growing primary cultures of human umbilical vein endothelial cells (HUVEC) with heparin binding growth factor 1 (HBGF-1) 20 micrograms/mL and heparin 12 U/mL inhibits expression of tissue factor (TF) activity on HUVC monolayers perturbed with thrombin. TF activity was measured as the ability of monolayers or cell lysates to support FVIIa-catalyzed activation peptide release from 3H-FX. TF antigen in HUVEC extracts was measured in an enzyme-linked immunosorbent assay (ELISA) that uses a double-antibody sandwich technique with rabbit and goat antibodies to human TF. TF-mRNA was measured by Northern blot hybridization with a 32P-TF cDNA probe. Cells growth with HBGF-1/heparin had both decreased surface and total TF activity as compared with HUVEC from the same endothelial cell pool grown without HBGF-1/heparin. Means +/- SD for TF antigen for four primary cultures were 4.4 +/- 0.9 ng/10(6) cells without HBGF-1/heparin and 0.6 +/- 0.3 ng/10(6) cells with HBGF-1/heparin. TF mRNA 4 hours after incubation with thrombin of HUVEC grown without HBGF-1/heparin was about sevenfold higher than TF mRNA of HUVEC grown with HBGF- 1/heparin. These data establish that growing primary cultures of HUVEC with HBGF-1/heparin impairs their ability to synthesize TF apoprotein after perturbation. This may be part of a generalized response of endothelial cells to HBGF-1/heparin facilitating migration during angiogenesis.

[1]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[2]  S. Rapaport,et al.  Localization of human tissue factor antigen by immunostaining with monospecific, polyclonal anti-human tissue factor antibody. , 1990, Thrombosis research.

[3]  H. Prydz,et al.  Observations on the Cell Biology of Tissue Factor in Endothelial Cells , 1990, Thrombosis and Haemostasis.

[4]  S. Rapaport,et al.  Functional Properties of Factor VIIa/Tissue Factor Formed with Purified Tissue Factor and with Tissue Factor Expressed on Cultured Endothelial Cells , 1989, Thrombosis and Haemostasis.

[5]  J. Sadler,et al.  Regulation of endothelial cell coagulant properties. Modulation of tissue factor, plasminogen activator inhibitors, and thrombomodulin by phorbol 12-myristate 13-acetate and tumor necrosis factor. , 1989, The Journal of biological chemistry.

[6]  T. Drake,et al.  Functional tissue factor is entirely cell surface expressed on lipopolysaccharide-stimulated human blood monocytes and a constitutively tissue factor-producing neoplastic cell line , 1989, The Journal of cell biology.

[7]  N. Blaes,et al.  Decreased prostacyclin production by human umbilical vein endothelial cells cultured with endothelial cell growth factor and heparin. , 1989, Thrombosis Research.

[8]  S. Rapaport,et al.  Studies of the Factor Xa-Dependent Inhibitor of Factor VIIa/Tissue Factor (Extrinsic Pathway Inhibitor) from Cell Supernates of Cultured Human Umbilical Vein Endothelial Cells , 1989, Thrombosis and Haemostasis.

[9]  S. Rapaport,et al.  Inhibition of factor VIIa/tissue factor-induced blood coagulation: with particular emphasis upon a factor Xa-dependent inhibitory mechanism. , 1989, Blood.

[10]  M. Yamamoto,et al.  Stimulation of cell growth and inhibition of prostacyclin production by heparin in human umbilical vein endothelial cells , 1988, Journal of cellular physiology.

[11]  L. Rao,et al.  Characterization of anti-tissue factor antibody and its use in immunoaffinity purification of human tissue factor. , 1988, Thrombosis research.

[12]  D. Ginsburg,et al.  The addition of endothelial cell growth factor and heparin to human umbilical vein endothelial cell cultures decreases plasminogen activator inhibitor-1 expression. , 1988, The Journal of clinical investigation.

[13]  J. Miletich,et al.  Cloning and characterization of a cDNA coding for the lipoprotein-associated coagulation inhibitor shows that it consists of three tandem Kunitz-type inhibitory domains. , 1988, The Journal of biological chemistry.

[14]  S. Rapaport,et al.  Decreased inducibility of tissue factor activity on human umbilical vein endothelial cells cultured with endothelial cell growth factor and heparin. , 1988, Thrombosis research.

[15]  T. Edgington,et al.  Molecular cloning of the cDNA for tissue factor, the cellular receptor for the initiation of the coagulation protease cascade , 1987, Cell.

[16]  S. Rapaport,et al.  Studies of a mechanism inhibiting the initiation of the extrinsic pathway of coagulation. , 1987, Blood.

[17]  S. Rapaport,et al.  Inhibition of tissue factor/factor VIIa activity in plasma requires factor X and an additional plasma component. , 1985, Blood.

[18]  R. Cotran,et al.  Interleukin 1 (IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells , 1984, The Journal of experimental medicine.

[19]  E. Bjørklid,et al.  Production and availability of thromboplastin in endothelial cells: the effects of thrombin, endotoxin and platelets , 1984, British journal of haematology.

[20]  N. Semeraro,et al.  Cultured human endothelial cells generate tissue factor in response to endotoxin. , 1983, The Journal of clinical investigation.

[21]  P. Majerus,et al.  Purification and characterization of human coagulation factor V. , 1981, The Journal of biological chemistry.

[22]  G. Ashwell,et al.  Studies on the chemical and enzymatic modification of glycoproteins. A general method for the tritiation of sialic acid-containing glycoproteins. , 1971, The Journal of biological chemistry.

[23]  Y. Nemerson,et al.  Binding of the protein component of tissue factor to phospholipids. , 1970, Biochemistry.

[24]  N. A. Kefalides,et al.  The effect of heparin on fibronectin and thrombospondin synthesis and mRNA levels in cultured human endothelial cells. , 1990, Experimental cell research.

[25]  T. Maciag,et al.  The heparin-binding (fibroblast) growth factor family of proteins. , 1989, Annual review of biochemistry.

[26]  S. Rapaport,et al.  A simplified procedure for purification of human prothrombin, factor IX and factor X. , 1981, Preparative biochemistry.